Blueprint Medicines Corp
F:2L9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Blueprint Medicines Corp
F:2L9
|
US |
|
S
|
Starmet Ventures Inc
CNSX:STAR
|
CA |
|
P
|
Prospect Ridge Resources Corp
CNSX:PRR
|
CA |
|
V
|
Vext Science Inc
XMUN:VV5
|
CA |
|
Far East Consortium International Ltd
F:FET
|
KY |
|
Erria A/S
CSE:ERRIA
|
DK |
|
C
|
Canadian Chrome Company Inc
CNSX:CACR
|
CA |
|
T
|
Tong Hua Holding PCL
SET:TH
|
TH |
|
Western Uranium & Vanadium Corp
OTC:WSTRF
|
CA |
|
N
|
Netx Holdings Bhd
KLSE:NETX
|
MY |
|
B
|
Bank Rakyat Indonesia (Persero) Tbk PT
XMUN:BYRA
|
ID |
Bankruptcy Probability
Blueprint Medicines Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Blueprint Medicines Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
B
|
Blueprint Medicines Corp
F:2L9
|
7.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
496.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
85.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Blueprint Medicines Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Blueprint Medicines Corp has total debt of 343.9m USD. This includes both short-term (0 USD) and long-term (343.9m USD) debt.
You can find a full breakdown on its Balance Sheet.